Home > Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) > Project Listing by Category

Project Listing by Category

Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC)

Click the column headings to sort project listings.

Category	Funding IC	Project Number	Sub Project #	Project Title	PI Name	Org Name	State / Country	Amount
ALS	NINDS	5U01NS050094-03		Characterizing Beta Lactams as Neuroprotectants for Amyotrophic Lateral Sclerosis	ROTHSTEIN, JEFFREY	JOHNS HOPKINS UNIVERSITY	MD	$322,944
ALS	NIGMS	5R01GM054111-11		Copper Protein In Metal and Oxidant Stress Responses	O'HALLORAN, THOMAS	NORTHWESTERN UNIVERSITY	IL	$311,439
ALS	NINDS	5R01NS046615-04		Heat Shock Proteins and Motoneuron Survival	MILLIGAN, CAROL	WAKE FOREST UNIVERSITY HEALTH SCIENCES	NC	$314,648
ALS	NINDS	5R01NS036548-07		AMPA/Kainate Receptors, Free Radicals, And Motor Neuron Injury	WEISS, JOHN	UNIVERSITY OF CALIFORNIA IRVINE	CA	$333,174
ALS	NINDS	5R01NS050557-04		High-Throughput Genomic Approaches to Identify ALS Genes	BROWN, ROBERT	MASSACHUSETTS GENERAL HOSPITAL	MA	$495,019
ALS	NINDS	5R01NS033958-13		Neuronal vs. glial glutamate transport regulation in ALS	ROTHSTEIN, JEFFREY	JOHNS HOPKINS UNIVERSITY	MD	$424,354
ALS	NINDS	5R01NS038679-08		Non-viral Delivery of Neurotrophic Factors to the CNS	FRANCIS, JONATHAN	MASSACHUSETTS GENERAL HOSPITAL	MA	$544,805
ALS	NIGMS	5F31GM077078-03		Role of Yeast Sen1p in RNA Maturation Pathways (Predoctoral Fellowhips for Studen	FINKEL, JONATHAN	UNIVERSITY OF WISCONSIN MADISON	WI	$29,907
ALS	NINDS	5R21NS054934-02		Identification of Protein Biomarkers for ALS	LIU, JIAN	CALIFORNIA PACIFIC MED CTR RES INSTITUTE	CA	$240,188
ALS	NINDS	5U01NS049640-04		Clinical Trial of Ceftriaxone in ALS	CUDKOWICZ, MERIT	MASSACHUSETTS GENERAL HOSPITAL	MA	$6,125,934
ALS	NINDS	5R01NS051288-03		Imaging Mitochondrial Function in Excitotoxicity	SHUTTLEWORTH, CLAUDE	UNIVERSITY OF NEW MEXICO	NM	$260,323
ALS	NINDS	5R01NS040494-08		Bicarbonate Enhances Peroxidation of SOD/ALS Mutants	KALYANARAMAN, BALARAMAN	MEDICAL COLLEGE OF WISCONSIN	WI	$285,958
ALS	NINDS	5R01NS052325-03		Trophic Factor Signaling and Motor Neuron Death	KALB, ROBERT	CHILDREN'S HOSPITAL OF PHILADELPHIA	PA	$287,877
ALS	NINDS	5R01NS051723-03		Time-lines of neural degeneration in ALS-PDC mouse model	SHAW, CHRISTOPHER	UNIVERSITY OF BRITISH COLUMBIA	CANADA	$262,170
ALS	NINDS	5R01NS055746-02		Mechanisms of motor neuron toxicity in Kennedy Disease	LIEBERMAN, ANDREW	UNIVERSITY OF MICHIGAN AT ANN ARBOR	MI	$319,214
ALS	NINDS	1R01NS055315-01A2		Mechanisms of SOD1 toxicity in ALS	ELLIOTT, JEFFREY	UNIVERSITY OF TEXAS SW MED CTR/DALLAS	TX	$309,094
ALS	NINDS	1R01NS058888-01A1		Ca2+ mishandling and ischemia-vulnerability in fALS model motor terminals	DAVID, GAVRIEL	UNIVERSITY OF MIAMI SCHOOL OF MEDICINE	FL	$301,219
ALS	NIGMS	5R01GM080742-02		Protein misfolding and aggregation	DOKHOLYAN, NIKOLAY	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$261,936
ALS	NINDS	5R21NS058538-02		Aberrant VEGF RNA Stability in Amyotrophic Lateral Sclerosis	KING, PETER	UNIVERSITY OF ALABAMA AT BIRMINGHAM	AL	$158,594
ALS	NIGMS	2R01GM064631-06		Structure/Function of Mn and Fe Superoxide Dismutases and Related Enzymes	BRUNOLD, THOMAS	UNIVERSITY OF WISCONSIN MADISON	WI	$219,826
ALS	NINDS	5R21NS053770-02		Silencing mutant SOD1 in vivo for treatment of ALS	XU, ZUOSHANG	UNIV OF MASSACHUSETTS MED SCH WORCESTER	MA	$178,403
ALS	NIDCD	5R01DC003723-09		Articulatory Kinematics in Neurogenic Speech Disorders	WEISMER, GARY	UNIVERSITY OF WISCONSIN MADISON	WI	$486,725
ALS	NINDS	5K23NS055200-02		Pilot Placebo-Controlled Trial of Early Noninvasive Ventilation for ALS	GRUIS, KIRSTEN	UNIVERSITY OF MICHIGAN AT ANN ARBOR	MI	$173,340
ALS	NINDS	5R01NS048145-05		Understanding mechanism and therapy of ALS using RNAi	XU, ZUOSHANG	UNIV OF MASSACHUSETTS MED SCH WORCESTER	MA	$348,635
ALS	NINDS	5R01NS051462-04		Increased persistent sodium current in SOD1 motoneurons	HECKMAN, CHARLES	NORTHWESTERN UNIVERSITY	IL	$314,445
ALS	NINDS	5R01NS040014-07		Mechanisms & Mouse Models of Amyotrophic Lateral Sclerosis	WONG, PHILIP	JOHNS HOPKINS UNIVERSITY	MD	$358,750
ALS	NINDS	5R01NS045893-05		Prospective Epidemiological Study of ALS	ASCHERIO, ALBERTO	HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)	MA	$290,173
ALS	NINDS	1F32NS059155-01A1		Transplantation of glial precursors: Astrocyte replacement in ALS	LEPORE, ANGELO	JOHNS HOPKINS UNIVERSITY	MD	$55,778
ALS	NINDS	5R37NS027036-21		Neurofilaments, SOD1 and Motor Neuron Diseases	CLEVELAND, DON	LUDWIG INSTITUTE FOR CANCER RESEARCH	CA	$576,188
ALS	NINDS	1F31NS060532-01A1		Synaptic & intrinsic motoneuron excitability in ALS excitotoxicity	SCHUSTER, JENNA	NORTHWESTERN UNIVERSITY	IL	$40,972
ALS	NIGMS	5R01GM054836-12		Folding Mechanisms of Dimeric Beta-Barrel Proteins	MATTHEWS, C	UNIV OF MASSACHUSETTS MED SCH WORCESTER	MA	$277,343
ALS	NINDS	5R01NS050641-05		Genetics of ALS	SIDDIQUE, TEEPU	NORTHWESTERN UNIVERSITY	IL	$710,637
ALS	NINDS	5R01NS051419-03		The Pathogenic Mechanisms of Mutant SOD1 in Mitochondria	MANFREDI, GIOVANNI	WEILL MEDICAL COLLEGE OF CORNELL UNIV	NY	$293,630
ALS	NINDS	5R01NS041646-09		Identification of genes that delay ALS onset	KUNST, CATHERINE	UNIVERSITY OF DENVER	CO	$337,890
ALS	NINDS	5R01NS041648-08		MODELS OF SBMA MOTOR NEURON DEGENERATION	LA SPADA, ALBERT	UNIVERSITY OF WASHINGTON	WA	$332,409
ALS	NINDS	5R01NS051764-03		The Role of Iduna in Neuroprotection	DAWSON, VALINA	JOHNS HOPKINS UNIVERSITY	MD	$398,110
ALS	NCCAM	5R21AT003632-02		A modified dietary regiment as a potential novel therapeutic intervention in ALS.	PASINETTI, GIULIO	MOUNT SINAI SCHOOL OF MEDICINE OF NYU	NY	$207,638
ALS	NINDS	5R01NS050674-04		Spatial Considerations in Neuronal Survival Signals	SEGAL, ROSALIND	DANA-FARBER CANCER INSTITUTE	MA	$374,947
ALS	NINDS	5R03NS054969-02		Neurotoxicity of sterol glucosides: role in ALS-PDC	SHAW, CHRISTOPHER	UNIVERSITY OF BRITISH COLUMBIA	CANADA	$33,233
ALS	NINDS	5R01NS039112-08		X-ray Studies of SOD in Amyotrophic Lateral Sclerosis	HART, PETER	UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT	TX	$318,974
ALS	NINDS	5R01NS040819-06		Mechanisms of Protection and Pathogenesis in Amyotrophic Lateral Sclerosis Mice	CROW, JOHN	UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK	AR	$372,125
ALS	NICHD	5R44HD053176-03		Reliable and Safe Laser Pointing for People with Locked-in Syndrome	JAKOBS, THOMAS	INVOTEK, INC.	AR	$169,513
ALS	NINDS	5R21NS054754-02		Identifying Pathogenic Protein Aggregates in ALS through Autocatalytic Misfolding	BOSQUE, PATRICK	DENVER HEALTH AND HOSPITAL AUTHORITY	CO	$151,080
ALS	NINDS	5R01NS056422-02		Role of Fas death receptor signaling in motor neuron degeneration	HENDERSON, CHRISTOPHER	COLUMBIA UNIVERSITY HEALTH SCIENCES	NY	$352,188
ALS	NINDS	5K08NS056212-03		Nogo's role in intracellular trafficking	HAREL, NOAM	YALE UNIVERSITY	CT	$158,765
ALS	NINDS	1K99NS062089-01		Mechanism of SOD1-linked ALS studied in C elegans and mouse models	WANG, JIOU	YALE UNIVERSITY	CT	$90,000
ALS	NINDS	1R21NS062180-01		Early motor neuron alteration in a non-cell autonomous ALS model	PRZEDBORSKI, SERGE	COLUMBIA UNIVERSITY HEALTH SCIENCES	NY	$203,740
ALS	NIEHS	5R01ES014469-03		Effect of Variation in Genes of Xenobiotic Responsive Proteins in ALS	SIDDIQUE, TEEPU	NORTHWESTERN UNIVERSITY	IL	$574,595
ALS	NINDS	1R21NS062230-01		Modeling TDP-43 Dysfunction in vivo	XU, ZUOSHANG	UNIV OF MASSACHUSETTS MED SCH WORCESTER	MA	$177,734
ALS	NIDCD	5R01DC006859-05		Perception of Dysarthric Speech	LISS, JULIE	ARIZONA STATE UNIVERSITY-TEMPE CAMPUS	AZ	$285,331
ALS	NIA	5R21AG029808-02		Proteomic Discovery in Parkinson-Dementia Complex of Guam	MONTINE, THOMAS	UNIVERSITY OF WASHINGTON	WA	$188,042
ALS	NIDCD	5R01DC004689-07		Therapeutic Approaches to Dysarthria: Acoustic and Perceptual Correlates	TJADEN, KRIS	STATE UNIVERSITY OF NEW YORK AT BUFFALO	NY	$259,304
ALS	NINDS	1R01NS054739-01A2		Transciption Factor Codes, Guidance Receptors and Motor Axon Guidance	BASHAW, GREG	UNIVERSITY OF PENNSYLVANIA	PA	$315,000
ALS	NINDS	1R01NS059708-01A1		Transgenic models of ALS caused by VAPB mutation	XU, ZUOSHANG	UNIV OF MASSACHUSETTS MED SCH WORCESTER	MA	$355,469
ALS	NICHD	1R21HD054913-01A2		Tilt/Recline Adjustment by Subjects with ALS using Brain Computer Interfaces	HUGGINS, JANE	UNIVERSITY OF MICHIGAN AT ANN ARBOR	MI	$258,183
ALS	NIGMS	5R37GM050016-16		Genetic Determinants of Oxygen Toxicity	CULOTTA, VALERIA	JOHNS HOPKINS UNIVERSITY	MD	$326,554
ALS	NINDS	1R03NS057693-01A2		Increasing DNA marker informativeness in hereditary canine motor neuron disease	PINTER, MARTIN	EMORY UNIVERSITY	GA	$76,500
ALS	NINDS	5F32NS055547-03		Genetic Analysis of Fas in Motor Neuron Cell Death	KANNING, KEVIN	COLUMBIA UNIVERSITY HEALTH SCIENCES	NY	$48,796
ALS	NINDS	5R01NS052179-04		Therapeutic Expression of Glial Glutamate Transporters	ROTHSTEIN, JEFFREY	JOHNS HOPKINS UNIVERSITY	MD	$358,502
ALS	NIEHS	5R01ES013244-05		Genetic Epidemiology of ALS in Veterans	SCHMIDT, SILKE	DUKE UNIVERSITY	NC	$433,467
ALS	NIA	5R37AG013617-14		METABOTROPIC GLUTAMATE RECEPTORS IN NEURODEGENERATION	YOUNG, ANNE	MASSACHUSETTS GENERAL HOSPITAL	MA	$324,784
ALS	NINDS	5K01NS052183-04		Toxic Probes of Axonopathy	TSHALA-KATUMBAY, DANIEL	OREGON HEALTH AND SCIENCE UNIVERSITY	OR	$156,814
ALS	NINDS	5R01NS049126-05		Proteomic and Functional Studies of Mitochondria in ALS	ZHU, HAINING	UNIVERSITY OF KENTUCKY	KY	$253,622
ALS	NINDS	1R21NS061257-01A1		Conformation-specific Single-chain Antibodies as Neurodegeneration Research Tools	SIERKS, MICHAEL	ARIZONA STATE UNIVERSITY-TEMPE CAMPUS	AZ	$176,394
ALS	NINDS	1R13NS062463-01		International Meeting on Plasticity and Disease of Motoneurons	BINDER, MARC	UNIVERSITY OF WASHINGTON	WA	$10,000
ALS	NINDS	1U13NS062682-01		Accelerating ALS Research: Translating Basic discoveries into Therapies for ALS	BRUIJN, LUCIE	AMYOTROPIC LATERAL SCLEROSIS ASSOCIATION	CA	$25,000
ALS	OD	1U13NS062682-01		Accelerating ALS Research: Translating Basic discoveries into Therapies for ALS	BRUIJN, LUCIE	AMYOTROPIC LATERAL SCLEROSIS ASSOCIATION	CA	$25,000
ALS	NINDS	1F31NS062583-01		Mechanisms of Virus Induced Motor Neuron Injury and Treatment of Viral Myelitis	SCHITTONE, STEPHANIE	UNIVERSITY OF COLORADO DENVER	CO	$32,772
ALS	NINDS	1F31NS062627-01		The Role of the Intrinsic Apoptotic Pathway in Familial ALS	REYES, NICHOLE	UNIVERSITY OF CALIFORNIA SAN FRANCISCO	CA	$30,865
ALS	NINDS	5U01NS052225-02		Development of New Therapeutics for Amyotrophic Lateral Sclerosis	BROWN, ROBERT	MASSACHUSETTS GENERAL HOSPITAL	MA	$629,008
ALS	NINDS	5R01NS051488-04		SOD1/Bc1-2 Complex: A Role in Regulating Motor Neuron Cell Death	PASINELLI, PIERA	THOMAS JEFFERSON UNIVERSITY	PA	$417,531
ALS	NINDS	5R21NS060182-02		Proteomic Markers for ALS	GLASS, JONATHAN	EMORY UNIVERSITY	GA	$167,344
ALS	NIMH	5R21EY018491-02		Gene Delivery to the CNS through the Deep Cerebellar Nucleus	KASPAR, BRIAN	RESEARCH INST NATIONWIDE CHILDREN'S HOSP	OH	$176,400
ALS	NINDS	5R01NS052514-02		Cortex Changes in Real/Imagined Movement in ALS	WELSH, ROBERT	UNIVERSITY OF MICHIGAN AT ANN ARBOR	MI	$375,643
ALS	NINDS	5U44NS059084-02		Intrathecal Cyclosporin for the Treatment of Amyotrophic Lateral Sclerosis (ALS)	KARLSSON, JENNY	MAAS BIOLAB, INC.	NM	$894,021
ALS	NINDS	1K08NS062890-01		A Drosophila model of motor neuron disease using mutations in P150 / Dynactin.	LLOYD, THOMAS	JOHNS HOPKINS UNIVERSITY	MD	$175,635
ALS	NIA	1R21AG032567-01		Role of p62 in Protein Aggregation and Neurodegeneration in ALS	ZHU, HAINING	UNIVERSITY OF KENTUCKY	KY	$231,250
ALS	NINDS	1R01NS060698-01A1		Mechanistic analysis of axonal transport defects in motor neuron degenerative dis	HOLZBAUR, ERIKA	UNIVERSITY OF PENNSYLVANIA	PA	$344,531
ALS	NIA	1R01AG029368-01A1		A Novel Neuroprotective Protein, Thorase	DAWSON, VALINA	JOHNS HOPKINS UNIVERSITY	MD	$334,970
ALS	NINDS	1R01NS058628-01A2		Superoxide Dismutase, Peroxynitrite and ALS	BECKMAN, JOSEPH	OREGON STATE UNIVERSITY	OR	$319,813
ALS	NINDS	1R01NS058980-01A2		Genetics of Gene Expression and Gene Mapping for Amytrophic Lateral Sclerosis	OPHOFF, ROEL	UNIVERSITY OF CALIFORNIA LOS ANGELES	CA	$330,250
ALS	NINDS	1R21NS060754-01A2		Abnormal Energy Homeostasis in ALS	KALB, ROBERT	CHILDREN'S HOSPITAL OF PHILADELPHIA	PA	$179,922
ALS	NINDS	1R21NS061049-01A1		Stem cell therapy targeting skeletal muscles for ALS	SUZUKI, MASATOSHI	UNIVERSITY OF WISCONSIN MADISON	WI	$194,906
ALS	NINDS	1R21NS058430-01A1		Selective CB2 Cannabinoid Agonists as Candidate Therapeutics for ALS	PRATHER, PAUL	UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK	AR	$188,053
ALS	NINDS	1R43NS063483-01		Novel Therapeutic for Amyotrophic Lateral Sclerosis (ALS)	SMITH, DAVID	ANGION BIOMEDICA CORPORATION	NY	$184,012
ALS	NINDS	1F32NS061464-01A1		Molecular basis of age-related synaptic alterations	VALDEZ, GREGORIO	HARVARD UNIVERSITY	MA	$51,278
ALS	NINDS	5F30NS060387-02		Combined Stem Cell and Anti-Oxidative Therapy for ALS	THONHOFF, JASON	UNIVERSITY OF TEXAS MEDICAL BR GALVESTON	TX	$27,187
ALS	RMAP	1DP1OD003930-01		Use of induced pluripotent stem cells to study mechanims of familial and sporadic	MANIATIS, THOMAS	HARVARD UNIVERSITY	MA	$835,500
ALS	NINDS	1R01NS064253-01		Pathogenesis of Neurodegenerative Diseases Caused by Mutations in Senataxin	NAGY, PETER	UNIVERSITY OF IOWA	IA	$328,125
ALS	NINDS	1R01NS064133-01		The Role of HuR in mutant SOD1 dysregulation of VEGF mRNA Processing	KING, PETER	UNIVERSITY OF ALABAMA AT BIRMINGHAM	AL	$307,344
ALS	NINDS	1K08NS057664-01A2		Dysregulation of VEGF RNA Stability in Amyotrophic Lateral Sclerosis	LU, LIANG	UNIVERSITY OF ALABAMA AT BIRMINGHAM	AL	$145,800
ALS	NINDS	1R21NS062189-01A1		Target Validation for Neurogenerative Disease Using Conditional RNAi in vivo	MAXWELL, MICHELE	MASSACHUSETTS GENERAL HOSPITAL	MA	$205,980
ALS	NINDS	1R01NS060874-01A2		Brain Metabolic Imaging in Amyotrophic Lateral Sclerosis	GOVINDARAJU, VARANAVASI	UNIVERSITY OF MIAMI SCHOOL OF MEDICINE	FL	$296,118
ALS	NINDS	1R01NS062766-01A1		Regulation of mitochondrial oxidative stress by Bcl-2 family proteins	LINSEMAN, DANIEL	UNIVERSITY OF DENVER	CO	$320,141
ALS	NINDS	1R21NS061084-01A2		CSF Indicators for Diagnosis and Disease Progression of ALS	MILLIGAN, CAROL	WAKE FOREST UNIVERSITY HEALTH SCIENCES	NC	$194,250
ALS	NINDS	5P01NS057778-02	0001	Respiratory Plasticity in the SOD1g93a Rat	MITCHELL, GORDON	UNIVERSITY OF WISCONSIN MADISON	WI	$343,651
ALS	NINDS	5P01NS057778-02	0002	Astrocytes Producting Growth Factors for ALS	SVENDSEN, CLIVE	UNIVERSITY OF WISCONSIN MADISON	WI	$327,191
ALS	NINDS	5P01NS057778-02	0003	Replacement of Motor Neurons and Astrocytes in ALS Using Human Embryonic Stem Cel	ZHANG, SU-CHUN	UNIVERSITY OF WISCONSIN MADISON	WI	$327,611
ALS	NIA	5P50AG016574-10	0005	Genetics of Frontotemporal Dementia (FTD) and Motor Neuron Disease	HUTTON, MICHAEL	MAYO CLINIC COLL OF MEDICINE, ROCHESTER	MN	$190,140
ALS	NINDS	5P01NS049134-04	0002	Structural and Biophysical Properties of Oligermeric SOD1	HART, P	UNIVERSITY OF CALIFORNIA LOS ANGELES	CA	$338,003
ALS	NINDS	5P01NS049134-04	0003	Testing Hypotheses by Site Directed Mutagenesis of SOD1	BORCHELT, DAVID	UNIVERSITY OF CALIFORNIA LOS ANGELES	CA	$358,786
ALS	NINDS	5P01NS049134-04	9001	Analytical	WHITELEGGE, JULIAN	UNIVERSITY OF CALIFORNIA LOS ANGELES	CA	$189,545
ALS	NINDS	3R01NS052325-03S1		Trophic Factor Signaling and Motor Neuron Death	KALB, ROBERT	CHILDREN'S HOSPITAL OF PHILADELPHIA	PA	$96,625
ALS	NIA	5P30AG013854-13	9001	CORE--CLINICAL	WEINTRAUB, SANDRA	NORTHWESTERN UNIVERSITY	IL	$593,611
ALS	NIA	5P30AG013854-13	9003	CORE--NEUROPATHOLOGY	BIGIO, EILEEN	NORTHWESTERN UNIVERSITY	IL	$255,241
ALS	NINDS	3R01NS048125-04S3		Clinical Trial of High Dose Coenzyme Q10 in Amyotrophic lateral Sclerosis	KAUFMANN, PETRA	COLUMBIA UNIVERSITY HEALTH SCIENCES	NY	$40,000
ALS	NINDS	3R01NS049126-05S1		Proteomic and Functional Studies of Mitochondria in ALS	ZHU, HAINING	UNIVERSITY OF KENTUCKY	KY	$73,250
ALS	NIA	5P01AG019724-07	0004	CLINICAL CRITERIA	MILLER, BRUCE	UNIVERSITY OF CALIFORNIA SAN FRANCISCO	CA	$275,881
ALS	NIA	5P01AG019724-07	9001	CLINICAL AND ADMINISTRATIVE	MILLER, BRUCE	UNIVERSITY OF CALIFORNIA SAN FRANCISCO	CA	$568,456
ALS	NINDS	3U01NS049640-04S1		Clinical Trial of Ceftriaxone in ALS	CUDKOWICZ, MERIT	MASSACHUSETTS GENERAL HOSPITAL	MA	$1,000,000
ALS	NINDS	5U54NS039407-09	0006	Manganese Superoxide Dismutase in Mechanisms of Aging and Neurodgeneration	DUTTAROY, ATANU	HOWARD UNIVERSITY	DC	$237,000
ALS	NIGMS	3R01GM080742-02S1		Protein misfolding and aggregation	DOKHOLYAN, NIKOLAY	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$27,706
ALS	NIA	Y2AG9075-24-0-1		Assessment of Primate Aging: Effects of Caloric Modification	NO PI IDENTIFIED			$1,300,000
ALS	NCRR	5M01RR000071-45	8284	USE OF PYRIMETHAMINE IN FAMILIAL ALS	LANGE, DALE	MOUNT SINAI SCHOOL OF MEDICINE OF NYU	NY	$24,541
ALS	NCRR	5M01RR007122-17	8352	CLINICAL TRIAL: CLINICAL TRIAL OF CEFTRIAXONE IN SUBJECTS WITH ALS	CARESS, JAMES	WAKE FOREST UNIVERSITY HEALTH SCIENCES	NC	$45,936
ALS	NCRR	5M01RR023940-02	8458	CLINICAL TRIAL: COQ10 IN ALS	BAROHN, RICHARD	UNIVERSITY OF KANSAS MEDICAL CENTER	KS	$11,733
ALS	NCRR	5M01RR000064-44	8615	CLINICAL TRIAL: EARLY TREATMENT OF ALS WITH NUTRITION AND NIPPV	BROMBERG, MARK	UNIVERSITY OF UTAH	UT	$3,438
ALS	NCRR	5M01RR000034-48	8724	CLINICAL TRIAL: CLINICAL TRIAL OF IGF-1 IN PATIENTS WITH AMYOTROPHIC LATERAL SCL	NASH, STEPHEN	OHIO STATE UNIVERSITY	OH	$2,079
ALS	NCRR	5M01RR000034-48	8752	STUDY OF SR 57746A IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS	KISSEL, JOHN	OHIO STATE UNIVERSITY	OH	$2,079
ALS	NCRR	5M01RR001346-27	8820	CLINICAL TRIAL: CLINICAL TRIAL OF HIGH DOSE COQ10 IN ALS	JACKSON, CARLAYNE	UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT	TX	$868
ALS	NCRR	5M01RR010732-14	8884	EARLY TREATMENT OF ALS W NUTRITION & NON-INVASIVE POSITIVE PRESSURE VENTILATION	SIMMONS, ZACHARY	PENNSYLVANIA STATE UNIV HERSHEY MED CTR	PA	$27,588
ALS	NCRR	5M01RR010732-14	5018	AN EVALUATION OF THE EFFECTS OF STRENGTH TRAINING ON ALS	SCOTT, KEVIN	PENNSYLVANIA STATE UNIV HERSHEY MED CTR	PA	$13,793
ALS	NCRR	5M01RR010732-14	5034	IMPAIRED REASONING & SOCIAL JUDGE IN FRONTOTEMPORAL LOBAR DEGEN IN ALS	FLAHERTY-CRAIG, CLAIRE	PENNSYLVANIA STATE UNIV HERSHEY MED CTR	PA	$2,029
ALS	NCRR	5M01RR010732-14	5098	ALS NUTRITION	SIMMONS, ZACHARY	PENNSYLVANIA STATE UNIV HERSHEY MED CTR	PA	$6,086
ALS	NCRR	5M01RR001032-33	5153	DIAPHRAGM TRAINING IN AMYOTROPHIC LATERAL SCLEROSIS	NARDIN, RACHEL	BETH ISRAEL DEACONESS MEDICAL CENTER	MA	$141
ALS	NCRR	5M01RR000109-44	5427	CLINICAL TRIAL: CLINICAL TRIAL OF HIGH DOSE COQ10 IN ALS	TANDAN, RUP	UNIVERSITY OF VERMONT & ST AGRIC COLLEGE	VT	$38,217
ALS	NCRR	5M01RR000109-44	5428	CLINICAL TRIAL: EARLY TREATMENT OF ALS WITH NUTRITION AND NIPPV	TANDAN, RUP	UNIVERSITY OF VERMONT & ST AGRIC COLLEGE	VT	$50,956
ALS	NCRR	5M01RR000109-44	5436	MEASURING QUALITY OF LIFE IN INDIVIDUALS WITH AMYOTROPHIC LATERAL SCLEROSIS	TANDAN, RUP	UNIVERSITY OF VERMONT & ST AGRIC COLLEGE	VT	$4,496
ALS	NCRR	5M01RR000109-44	5445	RADIOLOGICAL CORRELATES OF COGNITIVE DYSFUNCTION IN ALS	TANDAN, RUP	UNIVERSITY OF VERMONT & ST AGRIC COLLEGE	VT	$11,989
ALS	NCRR	2P41RR001646-26	7416	CRYSTALLOGRAPHIC STUDIES OF SIGNALING PROTEINSC	CHEN, XIAOMIN	CORNELL UNIVERSITY ITHACA	NY	$20,007
ALS	NCRR	5P41RR001209-29	7923	X-RAY ABSORPTION STUDIES OF MUTANTS OF COPPER/ZINC SUPEROXIDE DISMUTASE	DE BEER GEORGE, SERENA	STANFORD UNIVERSITY	CA	$962
ALS	NCRR	5P41RR001209-29	8092	AN ULTRAHIGH RESOLUTION CRYSTAL STRUCTURE OF CTX-M BETA-LACTAMASE FOR ENZYME STU	CHEN, YU	STANFORD UNIVERSITY	CA	$184
ALS	NCRR	5P41RR001209-29	8125	STRUCTURAL STUDIES OF FF DOMAINS	CHEN, XIAOMIN	STANFORD UNIVERSITY	CA	$184
ALS	NCRR	5P41RR008630-13	8857	SPINAL CORD METAL ACCUMULATION IN YOUNG ADULT AND AGED RAT	GERIN, CHRISTINE	ILLINOIS INSTITUTE OF TECHNOLOGY	IL	$18,984
ALS	NCRR	5P41RR011823-13	5905	ANALYZING MICROGLIA-DERIVED TOXICITY TO MOTOR NEURONS IN ALS	CLEVELAND, DON	UNIVERSITY OF WASHINGTON	WA	$8,075
ALS	NCRR	5M01RR000827-33	7111	A MULTI-CENTER, PHASE III, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, CLINIC	MOZAFFAR, TAHSEEN	UNIVERSITY OF CALIFORNIA SAN DIEGO	CA	$1,374
ALS	NCRR	5M01RR000827-33	7139	OPEN LABEL EXTENSION OF PROTOCOL AALS-001 (#AALS-001-OL) - ARIMOCLOMOL IN AMY	MOZAFFAR, TAHSEEN	UNIVERSITY OF CALIFORNIA SAN DIEGO	CA	$1,831
ALS	NCRR	5M01RR000827-33	7141	COMBINATION DRUG SELECTION TRIAL IN AMYOTROPHIC LATERAL SCLEROSIS	MOZAFFAR, TAHSEEN	UNIVERSITY OF CALIFORNIA SAN DIEGO	CA	$5,495
ALS	NCRR	2M01RR001066-31	8215	CLINICAL TRIAL: CLINICAL TRIAL OF HIGH DOSE COQ10 IN ALS	KRIVICKAS, LISA	MASSACHUSETTS GENERAL HOSPITAL	MA	$5,181
ALS	NCRR	2M01RR001066-31	8230	CLINICAL TRIAL: CLINICAL TRIAL OF CEFTRIAXONE IN SUBJECTS WITH ALS	KRIVICKAS, LISA	MASSACHUSETTS GENERAL HOSPITAL	MA	$8,742
ALS	NCRR	2M01RR001066-31	8235	CLINICAL TRIAL: PYRIMETHAMINE FOR TREATMENT OF SOD1 MEDIATED AMYLOTROPHIC LATERA	BROWN, ROBERT	MASSACHUSETTS GENERAL HOSPITAL	MA	$1,619
ALS	NCRR	2M01RR001066-31	8265	OPEN LABEL CREATINE MONOHYDRATE DOSAGE-ESCALATION STUDY	DIBERNARDO, ALLITIA	MASSACHUSETTS GENERAL HOSPITAL	MA	$5,666
ALS	NIA	1Z01AG000315-08		Dietary Modification Of Brain Aging And Neurodegenerative Disorders	MATTSON, MARK	NIH		$1,080,921
ALS	NIA	1Z01AG000933-01		Genome wide SNP analysis in Amyotrophic Lateral Sclerosis	SINGLETON, ANDREW	NIH		$191,764
ALS	NIA	1Z01AG000941-01		The Role of ALS2/Alsin in ALS and Motor Neuron Diseases	CAI, HUAIBIN	NIH		$299,151
ALS	NIA	1Z01AG000943-01		The Pathogenic Mechanism of ALS-related TDP-43 Mutations	CAI, HUAIBIN	NIH		$107,388
ALS	NIA	1Z01AG000946-01		The Function of dynactin p150glued in Axonal Transport and Motor Neuron Diseases	CAI, HUAIBIN	NIH		$155,329
ALS	NIA	1Z01AG000959-05		Pathobiological Studies of Neurodegenerative Diseases	CAI, HUAIBIN	NIH		$210,940
ALS	NCI	1Z01BC010822-02		Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation	BASRAI, MUNIRA	NIH		$824,008
ALS	NIEHS	1Z01ES049004-17		Statistical Methods In Human Development/clinical Studies	UMBACH, DAVID	NIH		$72,225
ALS	NIEHS	1Z01ES049005-17		Lead And Other Neurotoxins As Risk Factors For Amyotrophic Lateral Sclerosis	SANDLER, DALE	NIH		$69,588
ALS	NINDS	1Z01NS002976-10		Spinal And Peripheral Mechanisms Of Human Motor Control	FLOETER, MARY KAY	NIH		$725,290